Popular weight-loss drugs may play surprising role in cancer outcomes
GLP-1 drugs like Ozempic and Wegovy may lower cancer risk by altering the body's immune response, but researchers say key clinical trials are needed.
Covered by 1 source ·
Every side
-
Fox News
GLP-1 drugs like Ozempic and Wegovy may lower cancer risk by altering the body's immune response, but researchers say key clinical trials are needed.